Inovio Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
INO Inovio Pharmaceuticals Inc
MMP Magellan Midstream Partners LP
ELTK Eltek Ltd
LE Lands End Inc
WING Wingstop Inc
PUMP ProPetro Holding Corp
CHK Chesapeake Energy Corp
SALM Salem Media Group Inc
UGAZ VelocityShares 3x Long Natural Gas ETN Linked to the S&P GSCI? Natural Gas Index ER
UBSI United Bankshares Inc
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Inovio Pharmaceuticals, Inc. (Inovio) is a late-stage biotechnology company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), Ebola, Middle East Respiratory Syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, it has a pipeline of pre-clinical and clinical stage products that have generated in vivo immune responses.

Closing Price
$14.86
Day's Change
0.11 (0.75%)
Bid
--
Ask
--
B/A Size
--
Day's High
15.25
Day's Low
14.25
Volume
(Light)
Volume:
23,327,958

10-day average volume:
29,219,142
23,327,958

Display:

Providers:

UpdateCancel
6 providers
May 27, 2020
Thinking about trading stocks or options in Inovio Pharmaceuticals, Canopy Growth Corp, United Airlines, Rockwell Automation, or Wells Fargo?

InvestorsObserver issues critical PriceWatch Alerts for INO, CGC, UAL, ROK, and WFC. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

May 26, 2020
Shareholder Alert: Robbins LLP Is Investigating the Officers and Directors of Inovio Pharmaceuticals, Inc. (INO)

Shareholder rights law firm Robbins LLP announces that it is investigating the officers and directors of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) for breaches of fiduciary duties and violations of the Securities Exchange Act of 1934. Inovio is a...(BusinessWire)

INOVIO to Host Webinar "DNA Medicines: From COVID-19 to Cancer"

INOVIO (NASDAQ:INO), a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to protect and treat people from infectious diseases, cancer, and diseases associated with HPV, today announced it will hold a...(PR Newswire)

May 20, 2020
Vaccines Market to Exhibit 10.7% CAGR by 2026; Increasing Prevalence of Contagious Disease Globally to Stimulate Growth, states Fortune Business Insights(TM)

The global vaccines market size is expected to reach USD 93.08 Billion by 2020, while exhibiting a promising CAGR of 10.7% between 2019 and 2026. This is ascribable to factors such as increasing prevalence of deadly infectious disease and...(Globe Newswire)

Thinking about buying stock in Surface Oncology, Inovio Pharmaceuticals, American Airlines, Altimmune, or Aurora Cannabis?

NEW YORK, May 20, 2020 InvestorsObserver issues critical PriceWatch Alerts for SURF, INO, AAL, ALT, and ACB. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these...(PR Newswire)

Clinical Research and Development Efforts Booming in Midst of COVID-19 Health Crisis

Fighting the new global pandemic is a top priority in medical research and pharmaceutical development. Hundreds of organizations are working on innovations to reduce the impact of the disease and prevent further infection. An article from Johns...(PR Newswire)

INOVIO's COVID-19 DNA Vaccine INO-4800 Demonstrates Robust Neutralizing Antibody and T Cell Immune Responses in Preclinical Models

INOVIO (NASDAQ:INO) today announced the publication of the preclinical study data for IN0-4800, its COVID-19 DNA vaccine, demonstrating robust neutralizing antibody and T cell immune responses against coronavirus SARS-CoV-2. The study was published...(PR Newswire)

May 14, 2020
INOVIO's INO-5401 in Combination with PD-1 Inhibitor Libtayo(R) (cemiplimab) Demonstrates 85% of Newly Diagnosed Glioblastoma Patients Are Alive 12 Months Following Treatment

INOVIO (NASDAQ: INO) today announced that 85 percent (44 out of 52) of patients newly diagnosed with the deadly brain cancer glioblastoma multiforme (GBM) who received the company's DNA medicine INO-5401, in combination with INO-9012 and PD-1...(PR Newswire)

May 13, 2020
Thinking about buying stock in Capricor Therapeutics, Waitr, Takeda Pharmaceutical, Sorrento Therapeutics, or Inovio Pharmaceuticals?

InvestorsObserver issues critical PriceWatch Alerts for CAPR, WTRH, TAK, SRNE, and INO. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

May 12, 2020
LAWSUITS FILED AGAINST INO, MESA and WORX - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / May 12, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed...(Accesswire)

FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Inovio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - May 12, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Inovio Pharmaceuticals, Inc. (NASDAQ: INO) ("Inovio" or "the...(Newsfile)

CLASS ACTION UPDATE for INO, ANAB and HAFC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / May 12, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have...(Accesswire)

Efforts Accelerated to Quickly Find Effective Treatment and Vaccine to Prevent Coronavirus

The latest strategic attack on the coronavirus resembles a war time scenario. When generals find a weaknesses in the enemy's lines, it will need plenty of ammunition to win the battle. In this case, even before a vaccine or vaccines are proven...(PR Newswire)

INOVIO to Present at RBC Capital Markets Virtual Global Healthcare Conference

INOVIO (NASDAQ:INO) today announced that Dr. J. Joseph Kim, President and CEO, along with other members of management will present in a fireside discussion at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 19, 2020 at 2:30 p.m...(PR Newswire)

Barbuto & Johansson, P.A. Reminds Investors of Today's Deadline in the Inovio Pharmaceuticals Class Action and Encourages Shareholders with Losses Exceeding $100,000 to Contact the Firm

Barbuto & Johansson, P.A. ("BARJO") reminds investors that today is the last day to contact the Firm to learn more about the class action filed against Inovio Pharmaceuticals, Inc. (NASDAQGS: INO), and appointment of lead plaintiff. (Globe Newswire)

May 11, 2020
INOVIO 24 HOUR DEADLINE ALERT: FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuit Against Inovio Pharmaceuticals - INO

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until May 12, 2020 to file lead plaintiff applications in a securities class action lawsuit...(PR Newswire)

LAWSUITS FILED AGAINST INO, NCLH and HALL - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / May 11, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed...(Accesswire)

FINAL DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Inovio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los angeles, California--(Newsfile Corp. - May 11, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Inovio Pharmaceuticals, Inc. (NASDAQ: INO) ("Inovio" or "the...(Newsfile)

CORRECTION -- The Rosen Law Firm, P.A.

In a release issued today by The Rosen Law Firm, P.A. under the headline "INO FINAL DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Reminds Inovio Pharmaceuticals, Inc. Investors of Important May 11 Deadline in Securities Class Action Lawsuit - INO...(Globe Newswire)

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of INO, NCLH and SERV

NEW YORK, NY / ACCESSWIRE / May 11, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have...(Accesswire)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.